JW PHARMACEUTICAL (JW중외제약(주))
KOSPI Stock Code: 001060 | DART Corp Code: 00149947
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | JW PHARMACEUTICAL |
|---|---|
| Korean legal name | JW중외제약(주) |
| Alternate names | JW중외제약 |
| Market | KOSPI |
| Stock Code | 001060 |
| DART Corp Code | 00149947 |
| CEO | 대표이사 신영섭, 함은경(각자 대표이사) |
| Business Registration No. | 1188102477 |
| Corporate Registration No. | 1101110019342 |
| Established Date | 1945-08-08 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 경기도 과천시 과천대로7길 38 - |
| Homepage | https://www.jw-pharma.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001544 |
| verified_at | 2026-11-01T02:20:19.755Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001544
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 775,298,057,923 | KRW 719,375,756,340 |
| Operating Income (영업이익) | KRW 94,460,987,932 | KRW 82,488,136,816 |
| Net Income (당기순이익) | KRW 61,511,192,817 | KRW 65,040,120,873 |
| Total Assets (자산총계) | KRW 605,273,167,595 | KRW 604,598,517,283 |
| Total Liabilities (부채총계) | KRW 235,903,567,710 | KRW 275,111,775,158 |
| Total Equity (자본총계) | KRW 369,369,599,885 | KRW 329,486,742,125 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-08 | 20261008800667 | [Corrected description]Imposition of Fines, etc. | [기재정정]벌금등의부과 | JW중외제약 |
2026-09-29 | 20260929800726 | Decision on Acquisition of Shares or Investment Certificates of Other Corporations | 타법인주식및출자증권취득결정 | JW중외제약 |
2026-09-18 | 20260918800750 | [Corrected description]Imposition of Fines, etc. | [기재정정]벌금등의부과 | JW중외제약 |
2026-09-17 | 20260917000055 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | JW홀딩스 |
2026-09-17 | 20260917000035 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | JW홀딩스 |
2026-09-17 | 20260917800091 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | JW중외제약 |
2026-08-28 | 20260828800800 | Material Business Matters Related to Investment Decisions | 투자판단관련주요경영사항 | JW중외제약 |
2026-08-14 | 20260814803657 | Material Business Matters Related to Investment Decisions | 투자판단관련주요경영사항 | JW중외제약 |
2026-08-14 | 20260814004216 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | JW중외제약 |
2026-08-11 | 20260811800882 | Material Business Matters Related to Investment Decisions | 투자판단관련주요경영사항 | JW중외제약 |
2026-08-11 | 20260811800845 | Implementation and Operation of Compliance Program of the Fair Trade Commission | 공정거래자율준수프로그램운영현황(안내공시) | JW중외제약 |
2026-08-11 | 20260811800829 | Interim Report on Business Performance (Fair Disclosure) | 영업(잠정)실적(공정공시) | JW중외제약 |
2026-08-10 | 20260810800584 | Conversion of Different Classes of Shares into Common Shares | 종류주식의보통주식으로전환(안내공시) | JW중외제약 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001544 | verified_at: 2026-11-01T02:20:19.755Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.